Skip to main content

COVID-19 Pandemic Related Changes in Healthcare Utilization Among Insured Persons in the US and its Impact on Pharmacoepidemiologic Research

Basic Details
Date Posted
Status
Complete
Description

This project will examine trends in healthcare utilization among the insured population in the United States during the COVID-19 pandemic and understand the impact of these trends on designing pharmacoepidemiologic studies. This project has two aims:

  1. Describe existing literature regarding trends in insurance coverage, patient visits by care setting, and dispensings during 2020-2022 and characterize how these trends are reflected in the Sentinel Distributed Database. 
  2. Investigate how changes in utilization impact the design and analysis of an inferential query that incorporates data from the COVID-19 pandemic period (2020 forward). 

The overall goal is to develop recommendations that will inform design decisions for future studies conducted within the Sentinel System that incorporate data from 2020 and beyond.

Related Links
Related Link(s)
FDA Sentinel System's Coronavirus (COVID-19) Activities
Workgroup Leader(s)

Sarah Dutcher, PhD, MS; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD

Sruthi Adimadhyam, PhD, MS; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA

Workgroup Member(s)

José J. Hernández-Muñoz, RPh, MPH, MSc, PhD; Jamal Jones, PhD, MPH; Yandong Qiang, MS, PhD, MPH, MHS; Corinne Woods, RPh, MPH; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD

Noelle Cocoros, MPH, DSc; Joy Kolonoski, MPH; Caroline Hugh, MPH; Maria Kempner; Nathan Kim; Emma Whited; Derek Campbell; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA